Navigation Links
Feasibility of Multiplexing Bio-Plex Total Target and Phosphoprotein Assays

lexed with phosphoprotein assays?
Can a total target assay detect differences in protein concentration among samples?


Methods
We designed the study using HEK 293 cells, which respond to UV treatment by increasing the level of phosphorylation of several proteins. All proteins selected for the phosphoprotein assays in this study are activated by this treatment. The multiplex run (6-plex) included the following targets:

Total ERK2
Phospho-p53 (Ser15)
Phospho-p70 S6 kinase (Thr421/Ser424)
Phospho-ATF-2 (Thr71)
Phospho-JNK (Thr183/Tyr185)
Phospho-c-Jun (Ser63)

Untreated and UV-treated HEK 293 cell lysates were prepared according to methods detailed in the Bio-Plex phosphoprotein assay instruction manual. Both untreated HEK 293 and UVtreated HEK 293 cell lysates were tested at three different protein concentrations to test dose-response characteristics of the assays. Blank wells were included in the run, with cell lysis/assay buffer used to replace the cell lysate. Duplicates were run for each sample.


Results and Discussion
Total Target Assays Can Be Multiplexed With Phosphoprotein Assays for Distinct Targets
Data from a multiplex run of five phosphoprotein assays with a total ERK2 assay are presented in Figure 1. To show the results clearly, each phosphoprotein signal was plotted together with the total ERK2 assay signal. Although the phosphorylation levels found between UV-treated and untreated cell lysates varied, the total ERK2 signal level at the same protein concentration was very consistent bet
'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. Bio-Plex Cytokine Immunoassays and ELISA: Comparison of Two Methodologies in Testing Samples From Asthmatic and Healthy Children, Rev A
2. Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A
3. Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A
4. Selection of Standards for Bio-Plex Cytokine Assays, Rev A
5. Application of the Bio-Plex Cell Lysis Kit in Western Blot Analysis of Phosphoproteins, Rev A
6. Development of a Multiplex Bead-Based Assay for Antibody Screening of a Nonhuman Primate Colony on the Bio-Plex System
7. New Kit Generates Exceptionally Pure Total RNA for RT-PCR
8. High-Throughput Isolation of Total RNA
9. Isolate and Analyze Total RNA from Cells Harvested by Laser Capture Microdissection
10. Fast Isolation of Total RNA from Small Numbers of Cells
11. Total RNA Isolation Protocol 1,2,3
Post Your Comments:
(Date:7/3/2015)... ... 03, 2015 , ... The Alexander Group, a 30-year old, ... alike-- typically known for its consummate professionalism-- embarks each year in a whacky ... from their day jobs. , "Our motto has always been work hard play ...
(Date:7/3/2015)... 2015  Pomerantz LLP announces that a class action ... or the "Company")(NYSE: PBYI ) and certain of ... District Court, Central District of California ... a class consisting of all persons or entities who ... 13, 2015 inclusive (the "Class Period").  This class action ...
(Date:7/2/2015)... 2015  Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual ... of intellectual property, today announced a litigation update. ... Verizon Services Corp. et al. , Case No. 1:14-cv-00721-GBL-TCB, ... District of Virginia , the Court ... certain key claims in favor of the Defendants on ...
(Date:7/1/2015)... ... 01, 2015 , ... It is now possible to separate two common disorders: ... computed tomography (SPECT) according to researchers from Amen Clinics, UCLA, Thomas Jefferson University, ... and is believed to be the largest brain imaging study ever, will be published ...
Breaking Biology Technology:The Alexander Group Declares Their Independence with a Bit of Levity 2SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 2SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 3SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 4Spherix Issues A Litigation Update 2Spherix Issues A Litigation Update 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4
... European Partnerships, ALAMEDA, Calif., and PARIS, March ... Novartis Pharma AG to give Novartis,access to Singulex,s ... Program (ETAP). Terms of the collaboration,were not disclosed. ... a,facility in Paris, France to support the needs ...
... March 6 VaxGen,Inc. (Pink Sheets: VXGN), a biopharmaceutical ... recent cash balance, with a view to,ensuring that stockholders ... the company,s proposed merger with Raven biotechnologies,inc. VaxGen,s Board ... date for the,Special Meeting of Stockholders to vote on ...
... Conference call scheduled for March 13, 2008 at 1:30 p.m. (Pacific); ... simultaneous webcast at http://www.adventrx.com , ... today announced that it will host a conference call and,webcast on ... to discuss fourth quarter and year end 2007 results. Evan M.,Levine, ...
Cached Biology Technology:Singulex Collaborates With Large Pharmaceutical Company in Erenna(TM) Technology Access Program 2VaxGen Reports Financial Update 2VaxGen Reports Financial Update 3VaxGen Reports Financial Update 4VaxGen Reports Financial Update 5VaxGen Reports Financial Update 6VaxGen Reports Financial Update 7
(Date:6/26/2015)... SPRINGVILLE, Utah , June 26, 2015 ATL ... assemblies and devices with specialties in single use solutions, headquartered ... acquisition of MedConx, Inc. (a California ... , and San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing ...
(Date:6/24/2015)... NEW YORK , June 24, 2015 ... favorable rate. The major drivers for the market include ... increasing number of new drug launches. Over the years, ... has increased. Between 2001 and 2010, the FDA approved ... addition, according to WIPO, Europe ...
(Date:6/24/2015)... 24, 2015 Biometry authentication provider KeyLemon ... password solution one face in. ... one face in, entering the expanding biometric authentication ... multifactor-authentication biometric answer to the password problem. With ... partnership with KeyLemon, one face in allows users ...
Breaking Biology News(10 mins):ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4KeyLemon Announces Partnership With Biometric Password Solution onefacein 2
... bring forth the best properties of both ever since ... Age. In the latest successful merger, researchers at the ... of Maryland (UM) and the U.S. Food and Drug ... substances that individually have generated interest for their potential ...
... SALT LAKE CITY An international consortium of researchers ... has reported that a study of nearly 2,300 people supports ... rare genetic changes called copy number variants (CNVs). The ... the Autism Genome Project (AGP), were published in Nature on ...
... - Researchers have discovered precisely why strands of some ... stretched, findings that could be used to improve industrial ... "Any kindergartner is familiar with this beading phenomenon, which ... between your thumb and forefinger," said Osman Basaran, Purdue,s ...
Cached Biology News:Liposome-hydrogel hybrids: No toil, no trouble for stronger bubbles 2Autism genome project identifies genetic variants that may make people susceptible to disorder 2Solution to beading-saliva mystery has practical purposes 2Solution to beading-saliva mystery has practical purposes 3
Inquire...
Homogenizing Solution, 18ml Proteinase K - [50ug/l] 75 l...
Rb anti-Occludin (C-term GST)...
anti-JNK2 Immunogen: Recombinant human JNK2 protein Accession Number: NM_002752 Quality Assurance: Routinely evaluated by immunoblot. Molecular Weight: 46 and/or 54 kDa Available ...
Biology Products: